While this specific case exclusively implicates the drug manufacturers as defendants, experts predict the rise of additional lawsuits targeting Ozempic, Mounjaro, and other GLP-1 drugs
Were officially at a point that every headline sounds like its drafted by a committee and then approved by a conclave of lawyers
Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al
Starting Your Journey with Confidence If you are considering starting a GLP-1 medication or are already on one, it is important to remember that most side effects are manageable
patients switched to placebo regained approximately 14.0% (Aronne et al., JAMA 2024
The correct framing is: "Weight-loss data suggests Zepbound 10 mg produces outcomes similar to Wegovy 2.4 mg